All Episodes
ASCO Daily News — 100 episodes
'No Margin for Error': What to Know Before Implementing AI in Clinical Practice
Groundbreaking Results Shift Treatment Paradigm in High-Risk Smoldering Multiple Myeloma
Navigating Therapeutic Advances in EGFR-Mutated NSCLC
Highlights From the 2026 ASCO GU Cancers Symposium
Personalizing Treatment in Head and Neck Cancers
Can Low-Dose Immunotherapy Expand Global Access to Cancer Care?
Highlights From the 2026 ASCO GI Cancers Symposium
Expanding Treatment Options for Breast Cancer: ADCs and Oral SERDs
What Challenges Will Oncologists Face in 2026?
What Frontline Treatment Should Be Used in Advanced Ovarian Cancer?
Managing Immune-Related Toxicities in Oncology
Key Takeaways From the 2025 ASCO Quality Care Symposium
Identifying Young BRCA Carriers With Breast Cancer: Early Detection Can Lead to Better Prognosis
Cancer and Aging: Researching the Path to Longer, More Vibrant Lives
Promising New Therapies in Non-Muscle Invasive Bladder Cancer
The Gut Microbiome and Immunotherapy: Researching the Connection
Why Are Early-Onset GI Cancers on the Rise?
What Is Precision Palliative Care? Rethinking a Care Delivery Problem
From Clinic to Clinical Trials: Responsible AI Integration in Oncology
Immunotherapy at ASCO25: Drug Development, Melanoma Treatment, and More
Innovations in GU Cancer Treatment at ASCO25
What Lung Cancer Abstracts Stood Out at ASCO25?
GI Cancer Research at ASCO25: Plenary Highlights and More
Breast Cancer Research Poised to Change Practice From ASCO25
Precision Oncology Advances in Hematologic Cancers at ASCO25
ASCO25 Recap: CHALLENGE, DESTINY-Breast09, and More
Day 5: Top Takeaways From ASCO25
Day 4: Top Takeaways from ASCO25
Day 3: Top Takeaways From ASCO25
Day 2: Top Takeaways From ASCO25
Day 1: Top Takeaways From ASCO25
ASCO25 Preview: Key Research Accelerating Cancer Care
Optimizing Oncology Clinical Pathways at the Point of Care
Personalizing Lung Cancer Management With ctDNA: Where We Are and Where We Are Headed
The Evolving Role of Precision Surgery in Gynecologic Cancers
Emerging Therapies in Acute Myeloid Leukemia
Practice-Informing Research Across GU Oncology: Highlights From GU25
Therapeutic Advances Across GI Cancers: Highlights From GI25
Advances in Adjuvant Therapy for High-Risk Early Breast Cancer With Germline Mutations
How to Advance Cancer Care for Native Americans
What Challenges Will Oncologists Face in 2025?
A New Standard of Care for Cervical Cancer: Assessing the KEYNOTE-A18 Study
Advances in Immunotherapy for Melanoma and Beyond
Personalizing Locoregional Treatment for Breast Cancer
How Are Cancer Centers Navigating IV Fluid Shortages and the Devastation of Hurricane Season?
Key Takeaways From the 2024 ASCO Quality Care Symposium
Key Takeaways From 2024 ASCO Breakthrough
How AI Can Improve Patient Identification and Recruitment for Clinical Trials
DESTINY-Breast06 and A-BRAVE: Advances in Breast Cancer Research
The Risks and Benefits of Taking a Break From Cancer Treatment
How to Enhance Early-Stage Breast Cancer Survivorship
Putting Patients First: Common Sense in Cancer Care
An Era of Promise for Cancer Vaccines
GU Oncology Highlights From ASCO24
Top ASCO24 Abstracts That Could Revolutionize Oncology
Enhancing Treatment Efficacy in Multiple Myeloma at ASCO24
ASCO24: Transforming the Lung Cancer Treatment Landscape
ESOPEC and Other Key GI Studies at ASCO24
Immunotherapy at ASCO24: NADINA and Other Key Studies
Day 4: Top Takeaways From ASCO24
Day 3: Top Takeaways From ASCO24
Day 2: Top Takeaways From ASCO24
Day 1: Top Takeaways From ASCO24
Key Abstracts in GU Cancers at ASCO24
Exploring CAR T Cells in GI Cancers at ASCO24
ASCO24: The Future of Personalized Immunotherapy
Novel Approaches in Hematologic Malignancies at ASCO24
ASCO24: The Era of the ADCs in NSCLC
Spotlight on Breast Cancer at ASCO24
Optimizing Novel Therapies and Surgery in Early-Stage NSCLC
A Revolution in Immunotherapy for Cervical and Endometrial Cancers
How ctDNA Is Advancing Care for Patients With GI Cancers
New Machine Learning Framework Uses EHR Data to Assess ICI Effectiveness, Toxicity
Innovations in CAR T-Cell Therapy for Multiple Myeloma
ADCs in Breast Cancer: Sequencing, Resistance, and Managing Toxicity
Advances in Precision Oncology for GI Cancers at GI24
Key Advances in Prostate, Kidney, and Bladder Cancers at GU24
What's New in Prostate Cancer, RCC, and mUC at GU24
Celebrating 20 Years of Evolution in GU Oncology
What the FDA CAR T-Cell Therapy Investigation Means for Oncologists
Managing the Complexities of Oncology Practice in 2024
Solutions and Key Research to Advance High-Quality Cancer Care
How to Implement Universal Germline Testing for CRC
Changing the Gut Microbiome to Improve the Efficacy of Immunotherapy
Navigating the Complexities of Next-Generation Endocrine Therapy in HR+ Breast Cancer
ASCO Breakthrough: Scientific Innovations and Emerging Technologies in Cancer Care
How Oncologists Are Confronting the Cancer Drug Shortage
AI Will Allow Doctors to Reclaim Time With Patients
Managing the Side Effects of Endocrine Therapy for Breast Cancer
The Emergence of Triplet Therapies in ccRCC in the Frontline Setting
Novel Therapies in GI Oncology at ASCO23
THOR, CONTACT-03, and Other Advances in GU Cancers at ASCO23
Spotlight on Immunotherapy at ASCO23
Highlights in Hematologic Malignancies at ASCO23
ADAURA, KEYNOTE-671, and Other Key Advances in Lung Cancer at ASCO23
SONIA, NATALEE, and Other Advances in Breast Cancer at ASCO23
Addressing the Impact of Prior Authorization on Access to Cancer Treatment
ASCO23: RELATIVITY-047, CheckMate-038, and Other Advances in Immunotherapy
ASCO23: COMMANDS, CAPTIVATE, and Key Studies in Hematologic Malignancies
ASCO23: Novel Approaches in RCC, mUC, and Prostate Cancer